Compare · DTOC vs HIMS
DTOC vs HIMS
Side-by-side comparison of Digital Transformation Opportunities Corp. (DTOC) and Hims & Hers Health Inc. (HIMS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DTOC and HIMS operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- HIMS is the larger of the two at $6.85B, about 17.0x DTOC ($403.5M).
- HIMS has hit the wire 9 times in the past 4 weeks while DTOC has been quiet.
- HIMS has more recent analyst coverage (25 ratings vs 0 for DTOC).
- Company
- Digital Transformation Opportunities Corp.
- Hims & Hers Health Inc.
- Price
- -
- -
- Market cap
- $403.5M
- $6.85B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2021
- 2019
- News (4w)
- 0
- 9
- Recent ratings
- 0
- 25
Digital Transformation Opportunities Corp.
Digital Transformation Opportunities Corp., a blank check company, intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses or entities. The company was founded in 2020 and is based in Bellevue, Washington.
Hims & Hers Health Inc.
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, collagen protein, biotin, and teas in the wellness category; moisturizer, fragrances, face wash, and anti-wrinkle creams in the skincare category; condoms and lubricants in the sexual health category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. It also offers medical consultation services; and engages in the wholesale of non-prescription product sales to retailers. Hims & Hers Health, Inc. is based in San Francisco, California.
Latest DTOC
- Divers Stephen covered exercise/tax liability with 3,369 shares, decreasing direct ownership by 34% to 6,524 units (SEC Form 4) (Amendment)
- New insider Divers Stephen claimed ownership of 37,499 shares and claimed ownership of 63,857 units of Class B Common Stock (SEC Form 3) (Amendment)
- Divers Stephen covered exercise/tax liability with 3,369 shares, decreasing direct ownership by 34% to 6,524 units (SEC Form 4)
- Divers Stephen was granted 9,893 shares (SEC Form 4) (Amendment)
- American Oncology Network, Inc. was granted 9,893 shares (SEC Form 4)
- SEC Form 424B5 filed by Digital Transformation Opportunities Corp.
- SEC Form EFFECT filed by Digital Transformation Opportunities Corp.
- SEC Form S-8 filed by Digital Transformation Opportunities Corp.
- Digital Transformation Opportunities Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SEC Form S-1/A filed by Digital Transformation Opportunities Corp. (Amendment)
Latest HIMS
- SEC Form 4 filed by Hims & Hers Health Inc.
- SEC Form 3 filed by Hims & Hers Health Inc.
- Hims & Hers to Announce Third Quarter 2026 Financial Results on November 9, 2026
- Hers Launches in Australia, Built to Care for the Whole Woman
- SEC Form 8-K filed by Hims & Hers Health Inc.
- Hims & Hers Names Jon Franklin as Chief Accounting Officer
- Chief Financial Officer Okupe Oluyemi sold $59,400 worth of shares (2,000 units at $29.70) as part of a pre-agreed trading plan, decreasing direct ownership by 0.85% to 234,527 units (SEC Form 4)
- Chief Legal Officer Boughton Soleil sold $100,957 worth of shares (3,461 units at $29.17) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 300,809 units (SEC Form 4)
- Hims & Hers Names Chief Medical Officers in the UK and Australia, Deepening its Investment in Local Clinical Leadership
- Chief Financial Officer Okupe Oluyemi sold $876,846 worth of shares (29,277 units at $29.95) as part of a pre-agreed trading plan and exercised 14,000 shares at a strike of $5.01, decreasing direct ownership by 6% to 236,527 units (SEC Form 4)